| Dr Anthony Louis Panariello, MD | |
|
203 Palisade Ave, Jersey City, NJ 07306-1112 | |
| (201) 653-5722 | |
| (201) 792-9718 |
| Full Name | Dr Anthony Louis Panariello |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 49 Years |
| Location | 203 Palisade Ave, Jersey City, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215036611 | NPI | - | NPPES |
| 4864204 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MA35054 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Palisade Eye Associates,p.c. | 1658455423 | 5 |
| Eye Centers Of America Llc | 7315125184 | 73 |
News Archive
Medical researchers may have uncovered a novel approach to treat an incurable and ultimately fatal neurodegenerative disease that affects hundreds of thousands of people.
To address the need for a high-quality neutralization assay against SARS-CoV-2, researchers from the NIAID modified and optimized a previously established fluorescence reduction neutralization assay (FRNA) to provide a quantitative assessment of a large number of infected cells through the use of a high-content imaging system.
According to a new study pregnancy and related hormonal changes that continue 12 weeks after giving birth increase a woman's risk of heart attack. Although the likelihood of having a heart attack during pregnancy is very low - just 1 in every 16,000 deliveries - it is still 3 to 4 times higher than non-pregnant women of the same age.
Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.
› Verified 8 days ago
| Entity Name | Palisade Eye Associates,p.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770664971 PECOS PAC ID: 1658455423 Enrollment ID: O20080304000035 |
News Archive
Medical researchers may have uncovered a novel approach to treat an incurable and ultimately fatal neurodegenerative disease that affects hundreds of thousands of people.
To address the need for a high-quality neutralization assay against SARS-CoV-2, researchers from the NIAID modified and optimized a previously established fluorescence reduction neutralization assay (FRNA) to provide a quantitative assessment of a large number of infected cells through the use of a high-content imaging system.
According to a new study pregnancy and related hormonal changes that continue 12 weeks after giving birth increase a woman's risk of heart attack. Although the likelihood of having a heart attack during pregnancy is very low - just 1 in every 16,000 deliveries - it is still 3 to 4 times higher than non-pregnant women of the same age.
Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.
› Verified 8 days ago
| Entity Name | Eye Centers Of America Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649563636 PECOS PAC ID: 7315125184 Enrollment ID: O20110627000073 |
News Archive
Medical researchers may have uncovered a novel approach to treat an incurable and ultimately fatal neurodegenerative disease that affects hundreds of thousands of people.
To address the need for a high-quality neutralization assay against SARS-CoV-2, researchers from the NIAID modified and optimized a previously established fluorescence reduction neutralization assay (FRNA) to provide a quantitative assessment of a large number of infected cells through the use of a high-content imaging system.
According to a new study pregnancy and related hormonal changes that continue 12 weeks after giving birth increase a woman's risk of heart attack. Although the likelihood of having a heart attack during pregnancy is very low - just 1 in every 16,000 deliveries - it is still 3 to 4 times higher than non-pregnant women of the same age.
Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony Louis Panariello, MD 203 Palisade Ave, Jersey City, NJ 07306-1112 Ph: (201) 653-5722 | Dr Anthony Louis Panariello, MD 203 Palisade Ave, Jersey City, NJ 07306-1112 Ph: (201) 653-5722 |
News Archive
Medical researchers may have uncovered a novel approach to treat an incurable and ultimately fatal neurodegenerative disease that affects hundreds of thousands of people.
To address the need for a high-quality neutralization assay against SARS-CoV-2, researchers from the NIAID modified and optimized a previously established fluorescence reduction neutralization assay (FRNA) to provide a quantitative assessment of a large number of infected cells through the use of a high-content imaging system.
According to a new study pregnancy and related hormonal changes that continue 12 weeks after giving birth increase a woman's risk of heart attack. Although the likelihood of having a heart attack during pregnancy is very low - just 1 in every 16,000 deliveries - it is still 3 to 4 times higher than non-pregnant women of the same age.
Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.
› Verified 8 days ago
Dr. Betty Ann Cervenak, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 203 Palisade Ave, Jersey City, NJ 07306 Phone: 201-653-5722 Fax: 201-792-9718 | |
Dr. Ganesh U Rau, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 203 Palisade Avenue, Jersey City, NJ 07306 Phone: 201-653-5722 Fax: 201-792-9718 | |
Dr. Cesar R. Samson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 600 Pavonia Ave, 6th Floor, Jersey City, NJ 07306 Phone: 201-963-5846 Fax: 201-963-8823 | |
Dr. Scott Michael Walsman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 Pavonia Ave, Jersey City, NJ 07306 Phone: 201-963-3937 | |
Barry A. Maltzman, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 600 Pavonia Ave, 6th Floor, Jersey City, NJ 07306 Phone: 201-963-5846 Fax: 201-963-8823 | |
Dr. William H. Constad, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 Pavonia Ave, 6th Floor, Jersey City, NJ 07306 Phone: 201-963-5846 Fax: 201-963-8823 |